Psomagen, Inc. (KOSDAQ:950200)
South Korea · Delayed Price · Currency is KRW 2,670.00
-80.00 (-2.91%)
At close: Nov 6, 2026
Psomagen Market Cap
Psomagen has a market cap or net worth of 51.36 billion as of November 5, 2026. It is the 31,615th most valuable company in the world and the 1,711th biggest in South Korea. Its market cap has decreased by 20.42% in one year.
Market Cap
51.36B
Enterprise Value
50.30B
Revenue
60.70B
Global Rank
Country Rank
#1,711 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 13, 2020, Psomagen's market cap has decreased from 254.61B to 51.36B, a decrease of -79.83%. That is a compound annual growth rate of -22.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 51.36B | -31.19% |
| Dec 30, 2025 | 74.64B | -4.20% |
| Dec 30, 2024 | 77.91B | -20.59% |
| Dec 28, 2023 | 98.10B | -34.17% |
| Dec 29, 2022 | 149.03B | -12.38% |
| Dec 30, 2021 | 170.10B | -50.35% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABION | 60.91B |
| IMGT Co.,Ltd. | 57.82B |
| PanGen Biotech | 55.41B |
| TegoScience | 53.72B |
| KoBioLabs | 51.46B |
| NovMetaPharma | 50.72B |
| Epibiotech | 48.21B |
| QuadMedicine | 47.71B |